{"transactions":[{"id":2100185,"issuer":{"id":6523,"kind":"organization","name":"NRX Pharmaceuticals, Inc."},"owners":[{"id":121957,"kind":"person","name":"Javitt Daniel C.","position":1,"cik":"0001864534","reported_name":"Javitt Daniel C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"common stock","published_at":"2022-12-01T19:29:11.000Z","date":"2022-11-30","kind":"sale","acquired":false,"shares":8441,"price":1.5046,"value":12700.3286,"ownership":{"direct":false,"nature":"by Glytech LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale was pursuant to the terms of a 10b5-1 trading plan established on June 13, 2022."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Held by Glytech LLC of which the Reporting Person is the sole owner."}],"balance_after":9634793,"source":{"system":"sec-edgar","filing":"0000880984-22-000017","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1864534/000088098422000017/primary_doc.xml","form_type":"4"}},{"id":2100184,"issuer":{"id":6523,"kind":"organization","name":"NRX Pharmaceuticals, Inc."},"owners":[{"id":121957,"kind":"person","name":"Javitt Daniel C.","position":1,"cik":"0001864534","reported_name":"Javitt Daniel C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"common stock","published_at":"2022-12-01T19:29:11.000Z","date":"2022-11-29","kind":"sale","acquired":false,"shares":13730,"price":1.5041,"value":20651.293,"ownership":{"direct":false,"nature":"by Glytech LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale was pursuant to the terms of a 10b5-1 trading plan established on June 13, 2022."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Held by Glytech LLC of which the Reporting Person is the sole owner."}],"balance_after":9643234,"source":{"system":"sec-edgar","filing":"0000880984-22-000017","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1864534/000088098422000017/primary_doc.xml","form_type":"4"}},{"id":2110521,"issuer":{"id":6523,"kind":"organization","name":"NRX Pharmaceuticals, Inc."},"owners":[{"id":121957,"kind":"person","name":"Javitt Daniel C.","position":1,"cik":"0001864534","reported_name":"Javitt Daniel C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"common stock","published_at":"2022-11-18T19:05:42.000Z","date":"2022-11-17","kind":"sale","acquired":false,"shares":33018,"price":1.0523,"value":34744.8414,"ownership":{"direct":false,"nature":"by Glytech LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale was pursuant to the terms of a 10b5-1 trading plan established on June 13, 2022."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Held by Glytech LLC of which the Reporting Person is the sole owner."}],"balance_after":9656964,"source":{"system":"sec-edgar","filing":"0000880984-22-000015","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1864534/000088098422000015/primary_doc.xml","form_type":"4"}},{"id":2110520,"issuer":{"id":6523,"kind":"organization","name":"NRX Pharmaceuticals, Inc."},"owners":[{"id":121957,"kind":"person","name":"Javitt Daniel C.","position":1,"cik":"0001864534","reported_name":"Javitt Daniel C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"common stock","published_at":"2022-11-18T19:05:42.000Z","date":"2022-11-16","kind":"sale","acquired":false,"shares":133719,"price":1.02,"value":136393.38,"ownership":{"direct":false,"nature":"by Glytech LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale was pursuant to the terms of a 10b5-1 trading plan established on June 13, 2022."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Held by Glytech LLC of which the Reporting Person is the sole owner."}],"balance_after":9689982,"source":{"system":"sec-edgar","filing":"0000880984-22-000015","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1864534/000088098422000015/primary_doc.xml","form_type":"4"}},{"id":2116384,"issuer":{"id":6523,"kind":"organization","name":"NRX Pharmaceuticals, Inc."},"owners":[{"id":121957,"kind":"person","name":"Javitt Daniel C.","position":1,"cik":"0001864534","reported_name":"Javitt Daniel C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"common stock","published_at":"2022-11-15T19:40:31.000Z","date":"2022-11-11","kind":"sale","acquired":false,"shares":49200,"price":1.0063,"value":49509.96,"ownership":{"direct":false,"nature":"by Glytech LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale was pursuant to the terms of a 10b5-1 trading plan established on June 13, 2022."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Held by Glytech LLC of which the Reporting Person is the sole owner."}],"balance_after":9823701,"source":{"system":"sec-edgar","filing":"0000880984-22-000014","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1864534/000088098422000014/primary_doc.xml","form_type":"4"}},{"id":2197848,"issuer":{"id":6523,"kind":"organization","name":"NRX Pharmaceuticals, Inc."},"owners":[{"id":121957,"kind":"person","name":"Javitt Daniel C.","position":1,"cik":"0001864534","reported_name":"Javitt Daniel C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-08-02T17:43:36.000Z","date":"2022-07-29","kind":"sale","acquired":false,"shares":784063,"price":1.0094,"value":791433.1922,"ownership":{"direct":false,"nature":"by Glytech LLC"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Held by Glytech LLC of which the Reporting Person is the sole owner."}],"balance_after":9872901,"source":{"system":"sec-edgar","filing":"0000880984-22-000009","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1864534/000088098422000009/primary_doc.xml","form_type":"4"}},{"id":2215005,"issuer":{"id":6523,"kind":"organization","name":"NRX Pharmaceuticals, Inc."},"owners":[{"id":121957,"kind":"person","name":"Javitt Daniel C.","position":1,"cik":"0001864534","reported_name":"Javitt Daniel C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-07-05T17:06:15.000Z","date":"2022-07-01","kind":"gift","acquired":false,"shares":2000000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"by Glytech LLC"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares were gifted to a charitable remainder unitrust."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Held by Glytech LLC of which the Reporting Person is the sole owner."}],"balance_after":10656964,"source":{"system":"sec-edgar","filing":"0000880984-22-000008","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1864534/000088098422000008/primary_doc.xml","form_type":"4"}},{"id":2240441,"issuer":{"id":6523,"kind":"organization","name":"NRX Pharmaceuticals, Inc."},"owners":[{"id":121957,"kind":"person","name":"Javitt Daniel C.","position":1,"cik":"0001864534","reported_name":"Javitt Daniel C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-06-07T20:11:10.000Z","date":"2022-06-07","kind":"sale","acquired":false,"shares":86459,"price":0.6461,"value":55861.1599,"ownership":{"direct":false,"nature":"by Glytech LLC"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Held by Glytech LLC of which the Reporting Person is the sole owner."}],"balance_after":12656964,"source":{"system":"sec-edgar","filing":"0000880984-22-000007","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1864534/000088098422000007/primary_doc.xml","form_type":"4"}},{"id":2240440,"issuer":{"id":6523,"kind":"organization","name":"NRX Pharmaceuticals, Inc."},"owners":[{"id":121957,"kind":"person","name":"Javitt Daniel C.","position":1,"cik":"0001864534","reported_name":"Javitt Daniel C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-06-07T20:11:10.000Z","date":"2022-06-06","kind":"sale","acquired":false,"shares":115657,"price":0.6653,"value":76946.6021,"ownership":{"direct":false,"nature":"by Glytech LLC"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Held by Glytech LLC of which the Reporting Person is the sole owner."}],"balance_after":12743423,"source":{"system":"sec-edgar","filing":"0000880984-22-000007","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1864534/000088098422000007/primary_doc.xml","form_type":"4"}},{"id":2240439,"issuer":{"id":6523,"kind":"organization","name":"NRX Pharmaceuticals, Inc."},"owners":[{"id":121957,"kind":"person","name":"Javitt Daniel C.","position":1,"cik":"0001864534","reported_name":"Javitt Daniel C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-06-07T20:11:10.000Z","date":"2022-06-03","kind":"sale","acquired":false,"shares":243596,"price":0.7024,"value":171101.8304,"ownership":{"direct":false,"nature":"by Glytech LLC"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Held by Glytech LLC of which the Reporting Person is the sole owner."}],"balance_after":12859080,"source":{"system":"sec-edgar","filing":"0000880984-22-000007","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1864534/000088098422000007/primary_doc.xml","form_type":"4"}},{"id":2529245,"issuer":{"id":6523,"kind":"organization","name":"NRX Pharmaceuticals, Inc."},"owners":[{"id":121957,"kind":"person","name":"Javitt Daniel C.","position":1,"cik":"0001864534","reported_name":"Javitt Daniel C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-11-02T16:06:27.000Z","date":"2021-07-16","kind":"gift","acquired":false,"shares":434594,"ownership":{"direct":false,"nature":"By Glytech LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Irrevocable gift by way of transfer to certain trusts established for the benefit of the Reporting Person's immediate family members. Neither the Reporting Person nor Glytech LLC received any compensation in respect of such transfers. Upon completion of such transfers, both the Reporting Person and Glytech LLC ceased to have any beneficial ownership or other interest in the shares subject to the transfers."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Held by Glytech, LLC of which the Reporting Person is the sole owner."}],"balance_after":13102676,"source":{"system":"sec-edgar","filing":"0000950142-21-003505","document":"es210197024_4-javittd.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1864534/000095014221003505/es210197024_4-javittd.xml","form_type":"4"}},{"id":2529244,"issuer":{"id":6523,"kind":"organization","name":"NRX Pharmaceuticals, Inc."},"owners":[{"id":121957,"kind":"person","name":"Javitt Daniel C.","position":1,"cik":"0001864534","reported_name":"Javitt Daniel C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-11-02T16:06:27.000Z","date":"2021-07-16","kind":"gift","acquired":false,"shares":434594,"ownership":{"direct":false,"nature":"By Glytech LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Irrevocable gift by way of transfer to certain trusts established for the benefit of the Reporting Person's immediate family members. Neither the Reporting Person nor Glytech LLC received any compensation in respect of such transfers. Upon completion of such transfers, both the Reporting Person and Glytech LLC ceased to have any beneficial ownership or other interest in the shares subject to the transfers."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Held by Glytech, LLC of which the Reporting Person is the sole owner."}],"balance_after":13537270,"source":{"system":"sec-edgar","filing":"0000950142-21-003505","document":"es210197024_4-javittd.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1864534/000095014221003505/es210197024_4-javittd.xml","form_type":"4"}},{"id":2674211,"issuer":{"id":6523,"kind":"organization","name":"NRX Pharmaceuticals, Inc."},"owners":[{"id":121957,"kind":"person","name":"Javitt Daniel C.","position":1,"cik":"0001864534","reported_name":"Javitt Daniel C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-06-10T18:48:09.000Z","date":"2021-05-24","kind":"grant","acquired":true,"shares":13971864,"ownership":{"direct":false,"nature":"By LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 24, 2021, pursuant to that certain Agreement and Plan of Merger dated December 13, 2020 (the \"Merger Agreement\") among NRX Pharmaceuticals, Inc. (f/k/a Big Rock Partners Acquisition Corp) (the \"Issuer\"), Big Rock Merger Corp., a Delaware corporation and wholly-owned, direct subsidiary of the Issuer (\"Merger Sub\"), and NeuroRx, Inc. (\"NeuroRx\"), Merger Sub merged with and into NeuroRx (the \"Merger\"), with NeuroRx surviving as a wholly owned subsidiary of the Issuer. Pursuant to the Merger Agreement, at the effective time of the Merger (the \"Effective Time\"), each share of NeuroRx common stock was automatically converted into the right to receive a pro rata portion of 50,000,000 shares of the Issuer's common stock and the contingent right to receive a pro rata portion of 25,000,000 shares of the Issuer's common stock (the \"Earnout Shares\") and Earnout Cash (as defined in the Merger Agreement)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Merger Agreement provides that the former shareholders of NeuroRx will receive a pro rata portion of the Earnout Shares if, prior to December 31, 2022, the NeuroRx COVID-19 Drug (i.e., ZYESAMI) receives emergency use authorization by the Food and Drug Administration (the ?FDA?) and NeuroRx submits and the FDA files for review a new drug application for the NeuroRx COVID-19 Drug (i.e., ZYESAMI) (the \"Earnout Shares Milestone\"). The Reporting Person?s right to receive additional shares pursuant to this earn-out right became fixed and irrevocable on May 24, 2021, the effective date of the Merger."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Held by Glytech, LLC of which the Reporting Person is the sole owner."}],"balance_after":13971864,"source":{"system":"sec-edgar","filing":"0000950142-21-001944","document":"es210157189_4-javittd.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1864534/000095014221001944/es210157189_4-javittd.xml","form_type":"4"}}]}